Lake Street Capital Has Lowered Expectations for Bioceres Crop Solutions (NASDAQ:BIOX) Stock Price

Bioceres Crop Solutions (NASDAQ:BIOX) had its target price trimmed by Lake Street Capital from $13.00 to $8.00 in a research note released on Friday,Benzinga reports. The brokerage currently has a buy rating on the stock.

Several other research analysts also recently weighed in on the stock. Canaccord Genuity Group decreased their target price on shares of Bioceres Crop Solutions from $9.50 to $7.00 and set a “buy” rating for the company in a research note on Friday. Oppenheimer lowered their target price on Bioceres Crop Solutions from $13.00 to $12.00 and set an “outperform” rating for the company in a research note on Tuesday, January 28th. Four analysts have rated the stock with a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, the stock has an average rating of “Buy” and an average price target of $10.00.

Bioceres Crop Solutions Trading Down 0.5 %

NASDAQ:BIOX opened at $5.55 on Friday. Bioceres Crop Solutions has a 12 month low of $5.50 and a 12 month high of $14.05. The business’s 50-day moving average is $6.62 and its two-hundred day moving average is $7.80. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.27 and a quick ratio of 0.87. The firm has a market capitalization of $348.04 million, a PE ratio of 277.64 and a beta of 0.57.

Bioceres Crop Solutions (NASDAQ:BIOX) last released its quarterly earnings results on Monday, November 11th. The company reported ($0.09) EPS for the quarter, missing the consensus estimate of $0.02 by ($0.11). Bioceres Crop Solutions had a return on equity of 0.68% and a net margin of 0.53%. The company had revenue of $92.60 million for the quarter, compared to analyst estimates of $117.15 million. During the same period last year, the firm posted ($0.07) earnings per share. Research analysts predict that Bioceres Crop Solutions will post 0.12 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Bioceres Crop Solutions

A number of institutional investors have recently modified their holdings of the stock. Ping Capital Management Inc. raised its stake in Bioceres Crop Solutions by 7.3% during the fourth quarter. Ping Capital Management Inc. now owns 44,000 shares of the company’s stock worth $268,000 after acquiring an additional 3,000 shares during the period. Stifel Financial Corp boosted its stake in Bioceres Crop Solutions by 33.4% in the third quarter. Stifel Financial Corp now owns 40,790 shares of the company’s stock valued at $321,000 after acquiring an additional 10,224 shares during the period. Dimensional Fund Advisors LP grew its holdings in shares of Bioceres Crop Solutions by 9.5% during the second quarter. Dimensional Fund Advisors LP now owns 61,330 shares of the company’s stock valued at $688,000 after purchasing an additional 5,341 shares during the last quarter. JPMorgan Chase & Co. raised its position in shares of Bioceres Crop Solutions by 49.3% during the 3rd quarter. JPMorgan Chase & Co. now owns 89,973 shares of the company’s stock worth $708,000 after purchasing an additional 29,693 shares during the period. Finally, Fourth Sail Capital LP lifted its holdings in shares of Bioceres Crop Solutions by 16.6% in the 4th quarter. Fourth Sail Capital LP now owns 3,698,961 shares of the company’s stock worth $22,490,000 after purchasing an additional 527,859 shares during the last quarter. Institutional investors and hedge funds own 17.68% of the company’s stock.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.